Skip to content
Home/Companies/MedTech/Maculaser

Maculaser

MedTech·Finland·Active·New
Entry
2026
Hold
New
Status
Active

Who owns Maculaser?

Maculaser is a Finnish MedTech company, currently owned by ZEISS Ventures since 2026.

Hand-verified · updated 2026-07-03

Open JSON · CC-BY
ZEISS Ventures
Investor
ZEISS Ventures
ZEISS Ventures CVC · 2019 · Evergreen

Key facts

HQFinland
SectorMedTech
StatusActive

More from ZEISS Ventures CVC

Other portfolio companies in the same fund.

Custom Surgical
Custom Surgical
Active
MedTechGermany· 2026
arcoris bio
Active
BiotechSwitzerland· 2025
Lidrotec
Active
Deep TechGermany· 2025
Odne
Active
MedTechSwitzerland· 2025
Surgify Medical
Active
MedTechFinland· 2025
Creal
Active
Deep TechSwitzerland· 2024

More PE-backed in MedTech

Comparable medtech deals from other GPs.

Acufocus, Inc.
Exited 2023
The Carlyle GroupUS
to Bausch + Lomb
Adicon Holdings Limited
Active
The Carlyle GroupUS
Aesynt
Exited 2016
Francisco PartnersUS
to Omnicell
Alere Medical, Inc.
Active
TA AssociatesUS
Alma Lasers, Ltd.
Alma Lasers, Ltd.
Active
TA AssociatesIsrael
Amedes Group
Active
General AtlanticGermany

Questions

Who owns Maculaser?

Maculaser is currently owned by ZEISS Ventures, through ZEISS Ventures CVC, since 2026.

When did ZEISS Ventures acquire Maculaser?

ZEISS Ventures acquired Maculaser in 2026.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue